Article
Biomolecular Targets for Platinum Antitumor Drugs
1 Apr 2002
Abstract excerpt
Cis-diamminedichloroplatinum(II) (cisplatin) is widely used for the treatment of testicular, ovarian, and other forms of cancer. Several second generation platinum centered antitumor drugs have been approved or undergoing phase-3 clinical trial. Cisplatin arrests the cell cycle at the G2 phase by a mechanism commonly known as apoptosis. At the molecular level, it is generally believed that the anticancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
